SAN DIEGO (AP) — SAN DIEGO (AP) — Kura Oncology Inc. (KURA) on Tuesday reported a loss of $73.3 million in its first quarter.
On a per-share basis, the San Diego-based company said it had a loss of 83 cents.
The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 88 cents per share.
The biopharmaceutical company posted revenue of $18.3 million in the period, also topping Street forecasts. Five analysts surveyed by Zacks expected $15.1 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KURA at https://www.zacks.com/ap/KURA
/Quantum%20Computing/A%20concept%20image%20with%20a%20brain%20on%20top%20of%20a%20blue%20circuit%20board_%20Image%20by%20Gorodenkoff%20via%20Shutterstock_.jpg)
/Microsoft%20logo%20on%20building%20by%20franz12%20via%20iStock.jpg)
